Fact-checked by Grok 2 weeks ago

Deliriant

Deliriants are a subclass of hallucinogenic substances characterized by their ability to induce a profound state of delirium through antagonism of muscarinic acetylcholine receptors in the central nervous system, resulting in symptoms such as severe confusion, disorientation, realistic and often nightmarish hallucinations, anterograde amnesia, hyperactivity, and autonomic effects including dry mouth, blurred vision, tachycardia, and hyperthermia. Unlike classic psychedelics that primarily affect serotonin receptors or dissociatives that target NMDA receptors, deliriants produce a dream-like yet terrifying altered state that users often describe as indistinguishable from psychosis, with little insight into the drug-induced nature of the experience. The pharmacology of deliriants centers on their properties, particularly as competitive antagonists at muscarinic receptors, which disrupts signaling essential for , , and ; this mechanism distinguishes them from other hallucinogens and underlies their unique behavioral profile, including impaired sensorimotor gating and altered affective states observed in preclinical models. Prominent examples include tropane alkaloids such as atropine, scopolamine, and hyoscyamine, which are naturally occurring in plants of the family, notably Datura stramonium (jimsonweed) and Brugmansia species, where they serve as chemical defenses but have been exploited for their psychoactive effects since ancient times. Additionally, certain pharmaceuticals exhibit deliriant effects at high doses, including diphenhydramine (found in over-the-counter antihistamines like ), which exerts secondary activity leading to similar hallucinatory and delirious states. Historically, these compounds have been used medicinally for millennia— alkaloids were documented in ancient , , and texts for treating , inducing , and even as poisons—while modern applications leverage their actions without the hallucinogenic risks at therapeutic doses. For instance, atropine is administered intravenously to reverse and or topically as a mydriatic for eye examinations, and scopolamine is utilized transdermally to prevent and . Despite these benefits, deliriants pose significant risks of , including life-threatening complications like seizures, , and cardiovascular instability, and their recreational use is uncommon due to the invariably dysphoric and amnesia-laden experiences they provoke.

Definition and Characteristics

Definition

Deliriants are a subclass of hallucinogenic substances that primarily induce a state of , defined as an acute disturbance in and characterized by , disorientation, and realistic hallucinations that the user perceives as genuine sensory experiences rather than distortions of reality. Unlike psychedelics, which typically produce insightful perceptual alterations through serotonin receptor agonism, or , which foster a sense of detachment via NMDA receptor antagonism, deliriants disrupt signaling in the , resulting in dream-like yet often terrifying states of altered . Common examples include anticholinergics like atropine and antihistamines such as diphenhydramine. The core symptoms of deliriant intoxication encompass profound , heightened , and a marked loss of testing, often accompanied by potential for violent or bizarre behaviors due to the profound disorientation. Users may exhibit restlessness, agitation, and hallucinatory experiences that blend seamlessly with perceived , leading to impaired judgment and increased risk of harm. These effects stem from the blockade of muscarinic receptors, though detailed mechanisms are explored elsewhere. Epidemiologically, deliriant exposures are more prevalent in accidental poisonings, particularly from plants containing tropane alkaloids or over-the-counter medications, than in intentional recreational use; for instance, the 2015 American Association of Poison Control Centers reported 576 single exposures to anticholinergic and 18,589 to diphenhydramine, with most cases arising unintentionally rather than for psychoactive effects. More recent data from 2022 indicates 26,248 single exposures to diphenhydramine, highlighting ongoing risks including misuse trends. Intentional misuse remains uncommon compared to other classes, contributing to its relative rarity in recreational contexts.

Etymology

The term "deliriant" derives from the Latin verb delirare, meaning "to deviate from a furrow" (as in plowing) or "to go mad," a metaphorical expression for straying from rational thought, with the noun form delirium entering English in the late 16th century to denote mental derangement. In medical contexts, delirium was first documented by the Roman encyclopedist Aulus Cornelius Celsus in the 1st century AD to describe acute confusional states associated with fever or trauma, building on earlier descriptions by Hippocrates around 400 BC of similar transient mental disturbances. By the 19th century, the adjective and noun "deliriant" emerged in English medical literature around the 1830s, referring to agents or conditions that induce delirium, particularly in toxicology where substances like atropine were classified as causing such states. In psychiatry, the term gained traction during the 1800s as part of evolving classifications of mental disorders, with "delirium" distinguishing acute, reversible confusional psychoses from chronic conditions like dementia, as detailed in early 19th-century texts on insanity. The related term "delirifacient," coined in the 19th century from Latin delirium and faciens ("making"), specifically denoted delirium-inducing substances in pharmacological writing, appearing in medical dictionaries by the mid-1800s to describe toxicants like certain alkaloids. In 20th-century , "deliriant" evolved into a distinct category for psychoactive substances, particularly anticholinergics, with the term introduced by David F. Duncan and Robert S. Gold in 1982 to differentiate them from psychedelics and based on their confusional rather than perceptual effects. This nomenclature arose amid post-1950s debates on classifying , where terms like "psychedelic" (coined by in 1957) and "hallucinogen" emphasized mind-manifesting or visual alterations, prompting distinctions for deliriants to highlight their delirium-like profile. Early toxicologists, such as Louis Lewin in his 1924 classification of mind-altering plants, influenced this adoption by grouping phantastica () separately from inebriants, laying groundwork for later refinements in deliriant terminology.

Pharmacological Aspects

Mechanism of Action

Deliriants primarily exert their psychoactive effects through competitive antagonism at muscarinic receptors (mAChRs), specifically the M1 through M5 subtypes, which disrupts and inhibits activity. This blockade prevents from binding to postsynaptic receptors in the central and peripheral nervous systems, leading to a range of physiological and cognitive disruptions characteristic of the deliriant class. The extent of receptor inhibition follows a dose-response relationship typical of competitive antagonists, described by the equation: \% \ inhibition = \frac{[D]}{[D] + IC_{50}} \times 100 where [D] represents the drug concentration and IC_{50} is the concentration producing 50% receptor blockade. For prototypical deliriants like , the IC_{50} at muscarinic receptors is approximately 55 nM, reflecting high potency in antagonizing these sites. Certain deliriants, notably first-generation antihistamines, additionally antagonize histamine H1 receptors, enhancing sedative effects through suppression of histaminergic arousal pathways in the . Unlike serotonergic hallucinogens that primarily activate 5-HT2A receptors or agents that block NMDA receptors, deliriants show negligible direct interactions with or systems, confining their hallucinogenic profile to mechanisms. Pharmacokinetically, deliriants demonstrate rapid absorption and onset, typically 15–60 minutes after oral ingestion, with effect durations ranging from 4 to 24 hours based on compound-specific factors such as dose and route. Metabolism occurs predominantly in the liver; antihistamine deliriants like diphenhydramine undergo extensive first-pass processing via cytochrome P450 enzymes, mainly CYP2D6, yielding active metabolites with elimination half-lives of 4–8 hours. In contrast, tropane alkaloid deliriants such as scopolamine exhibit quicker clearance, with a serum half-life of 2–3 hours following hepatic biotransformation and renal excretion. Differences in binding profiles exist across deliriant classes: alkaloids like display high-affinity, selective competitive antagonism at muscarinic receptors, while antihistamines engage these sites with lower potency alongside their primary H1 blockade, resulting in more varied pharmacokinetic behaviors.

Effects

Deliriants induce a range of psychological effects characterized by vivid and realistic hallucinations, often involving nonexistent people, , or other entities that users perceive as entirely real. These hallucinations are frequently accompanied by , heightened anxiety, and , where individuals fill memory gaps with fabricated details. A hallmark feature is , which prevents users from recalling the deliriant episode, contributing to the disorienting nature of the experience. Physiologically, deliriant intoxication manifests as the classic anticholinergic toxidrome, encompassing due to impaired , from sympathetic overdrive, leading to , , and dry mucous membranes resulting from reduced secretions. These symptoms are memorably summarized by the mnemonic: blind as a (mydriasis and visual disturbances), hot as a (), dry as a ( and anhidrosis), red as a beet (flushing), and mad as a ( and agitation). Cognitively, users experience severe impairments in judgment and heightened , often leading them to act on hallucinated commands or misinterpret reality, which can result in dangerous behaviors. The resulting typically persists for 12-48 hours, marked by profound and disorientation. The progression of effects is dose-dependent: low doses primarily cause and mild , while higher doses escalate to severe , seizures, or . Long-term risks, such as persistent cognitive deficits including memory impairment and , are rare but have been documented in cases of chronic abuse. Individual variability in effects is influenced by factors such as (with older individuals more susceptible to severe symptoms), pre-existing , and co-ingestion of substances; for instance, can exacerbate and intensify physiological distress. These symptoms arise from muscarinic receptor antagonism in the central and peripheral nervous systems.

Classification of Deliriants

Anticholinergics

deliriants represent the largest class of deliriant substances, characterized by their ability to block muscarinic receptors in the central and peripheral nervous systems, thereby inducing a state of profound marked by confusion, hallucinations, and disorientation. These compounds are predominantly alkaloids derived from plants in the family, such as Atropa, , and Hyoscyamus genera, which have been used historically for both medicinal and intoxicating purposes. Prominent examples include atropine, extracted from deadly nightshade (); scopolamine, obtained from jimsonweed (); and hyoscyamine, isolated from henbane (). These natural alkaloids occur in various parts of the plants, including leaves, seeds, and roots, with concentrations varying by species and environmental factors. Synthetic analogs, such as benztropine, mimic the tropane structure and exhibit similar effects, though they are primarily developed for therapeutic applications like treating . These substances are noted for their high potency and extended duration of effects, often resulting in lasting from 24 to 72 hours or longer, particularly with , due to its strong penetration and slow elimination. Plant-based exposures are the most common route, frequently involving accidental ingestion or intentional abuse of wild or cultivated plants, which can lead to unpredictable dosing and severe outcomes. The isolation of these alkaloids dates back to the , with atropine first purified in 1833 from by chemists Philipp L. Geiger and Rudolf Brandes, followed by hyoscyamine in 1833 and scopolamine in the 1880s. In modern medicine, scopolamine is employed in transdermal patches for preventing , highlighting its therapeutic value despite the recognized abuse potential that emerged in reports from the onward, when recreational misuse of plant sources and pharmaceuticals began to be documented in clinical literature.

Antihistamines

deliriants consist of first-generation H1 receptor antagonists characterized by significant off-target activity, which contributes to their hallucinogenic potential at supratherapeutic doses. Prominent examples include diphenhydramine (commonly marketed as ), dimenhydrinate (Dramamine), and , all of which readily cross the blood-brain barrier to exert effects. These agents belong to structural classes such as ethanolamines (e.g., diphenhydramine and dimenhydrinate) or piperazines, features that enhance their and CNS penetration. Their widespread over-the-counter availability has facilitated frequent misuse, particularly among adolescents seeking altered states. In high doses, typically ranging from 500 to 1500 mg for diphenhydramine, these antihistamines induce deliriant effects marked by intense sedation surpassing that of pure anticholinergics, alongside realistic hallucinations and cognitive disruption. Users commonly report visual phenomena such as "shadow people" or shadowy figures, often accompanied by dysphoria and confusion, distinguishing these experiences from more euphoric hallucinogens. The onset of peak effects occurs within 1-2 hours, with the deliriant phase lasting 4-8 hours, shorter than many other deliriants due to the drugs' pharmacokinetic profiles. Developed in the 1940s for managing allergies and , these compounds' deliriant properties emerged in through case reports of adolescent abuse starting in the . misuse now represents the majority of over-the-counter deliriant abuse cases, prompting U.S. warnings in the about severe risks including cardiac arrhythmias and seizures from excessive intake.

Other Classes

Beyond the primary categories of anticholinergics and antihistamines, deliriants encompass atypical substances with mechanisms that induce delirium-like states through non-acetylcholinergic pathways, though such examples are rare and often debated due to overlapping classifications with other types. One prominent case is , the primary psychoactive compound in mushrooms, which acts as an orthosteric agonist at ionotropic GABA_A receptors, leading to enhanced inhibitory neurotransmission that manifests as profound disorientation, confusion, and hallucinatory experiences resembling without the full anticholinergic syndrome of dry mouth, , or . This mechanism contrasts sharply with the excitatory blockade seen in classical deliriants, producing sedative-hypnotic effects alongside perceptual distortions that users may not recognize as drug-induced. Unique to this class, muscimol's deliriant effects are linked to sporadic mushroom poisonings, with lower prevalence compared to pharmaceutical deliriants; for instance, accidental ingestions of A. muscaria contribute to a subset of the estimated 100 annual hospitalizations from exposures in the , as reported in national health data, often involving gastrointestinal distress followed by neurological symptoms requiring supportive care. Clusters of cases, such as the acute intoxications documented in in 2018 among individuals of Karen ethnicity from mistaking the mushrooms for edible varieties, highlight the risks in foraging contexts, with symptoms including , hallucinations, and seizures resolving after 24-48 hours without long-term sequelae in most instances. Experimental in the 2020s has explored synthetic analogs of compounds for potential therapeutic modulation of states, though these remain preclinical and do not yet constitute established deliriants. Disputed inclusions in this category involve substances like , derived from , which exhibits a complex profile including receptor agonism and NMDA antagonism, occasionally producing deliriant elements such as oneiric visions and confusion amid its primary and anti-addictive effects, but is more accurately classified as a rather than a pure deliriant. Similarly, certain anesthetics like show overlaps with -induced disorientation but lack the characteristic realistic hallucinations of deliriants. Many purported "other" deliriants, such as various novel psychoactive substances, have been debunked as misclassifications upon toxicological review, emphasizing the need for evidence-based categorization focused on verifiable hallucinatory .

Uses and Risks

Recreational Use

Recreational use of deliriants primarily stems from the pursuit of intense, realistic hallucinations and dissociative "blackout" states, often appealing to adolescents due to the easy availability of over-the-counter substances like diphenhydramine (found in ). This motivation has fueled social media-driven trends, such as the that emerged in 2020 on , where users ingest excessive amounts to induce vivid perceptual distortions. Common methods involve oral ingestion of high doses of diphenhydramine, often in the range of several hundred milligrams, or consuming parts of plants like , including chewing seeds, brewing teas, or smoking dried leaves. These practices typically occur in solitary environments or small groups, with users influenced by online accounts sharing experiences. According to (NIDA) surveys, including Monitoring the Future data, past-year nonmedical use of over-the-counter medications like antihistamines remains low among youth, with rates around 2-4% as of 2024, though specific to deliriants like diphenhydramine, misuse is less commonly tracked but shows stable low prevalence. Temporary increases have been observed during events like the , amplified by discussions on online forums, and as of 2025, reports indicate rising misuse of OTC antihistamines among teens, with an 87% increase in pediatric ingestions from 2015-2024. Deliriants feature in cultural portrayals of altered , such as hallucinatory sequences in films depicting substance-induced and oblique references in music to toxic like . A major barrier to repeated use is the drugs' reputation for producing highly unpleasant, uncontrollable experiences marked by , , and physical discomfort, which often results in low rates of habitual consumption.

Therapeutic and Medical Contexts

Deliriants, primarily compounds, have established roles in medical practice due to their ability to block muscarinic receptors, which can mitigate specific physiological symptoms in controlled settings. is approved for preventing , administered via patches containing 1.5 mg of the base, which deliver approximately 1 mg over 72 hours following an initial . Atropine, another key deliriant, is widely used in to dilate pupils for eye examinations and treat conditions like by paralyzing the . In , atropine serves as a first-line agent to reverse symptomatic by increasing through vagal . Historically, has been employed as an for , reducing gastrointestinal motility and cramping. It also finds use in management to alleviate rigidity, tremors, and by countering excessive activity. In early 20th-century and , combined with induced "twilight sleep" during labor, aiming to provide and relief, though this practice declined due to unpredictable side effects. Ongoing research explores deliriants' potential in neurodegenerative and addictive disorders, tempered by their inherent toxicity. Selective muscarinic modulation, particularly targeting M1 receptors, shows promise for by enhancing cognitive function and reducing amyloid-beta pathology, as investigated in preclinical models and early agonist trials. Regulatory frameworks vary by compound and form; pure hallucinogenic extracts like those from (containing and atropine) are not federally scheduled in the as plants but face state-level restrictions in places like and , while low-dose deliriants, such as diphenhydramine, remain available over-the-counter for relief without hallucinogenic intent. The narrow of deliriants—exemplified by atropine's small margin between effective and toxic doses—poses significant challenges, restricting broader therapeutic exploration and necessitating precise dosing to avoid or cardiovascular complications. Recent investigations into deliriants for anxiety, post-2022, remain unproven, with no robust clinical evidence supporting efficacy or safety beyond anecdotal reports.

Toxicity and Overdose Management

Overdose of deliriants, particularly , can escalate the classic to life-threatening manifestations including seizures, , and , often due to or cardiac arrhythmias. While fatalities are uncommon, comprising less than 1% of reported cases, severe outcomes arise from and autonomic instability. varies by agent; for example, the oral LD50 of atropine in mice is approximately 75 mg/kg, though human fatal doses range widely from 1.6 mg to over 100 mg depending on individual factors. Key risk factors for deliriant overdose include , which exacerbates toxicity through synergistic effects on the , and accidental pediatric exposures, such as children mistaking berries or seeds for toys or food. In the United States, poison control centers receive thousands of annual calls related to anticholinergic exposures, with data from 2015 documenting approximately 14,000 exposures, many involving unintentional ingestions. Management of deliriant overdose prioritizes supportive care, including intravenous fluids for hydration, active cooling measures for , and monitoring for cardiopulmonary complications. The specific antidote , administered at 1-2 mg intravenously over 5 minutes, reverses muscarinic blockade by inhibiting , thereby increasing levels at synapses; repeat dosing may be needed every 20-30 minutes if initial response is inadequate, with atropine kept ready to counter potential excess. For agitation, intravenous benzodiazepines serve as first-line therapy to control seizures and without worsening effects. Long-term sequelae from deliriant overdose are rare but may include persistent with ongoing hallucinations or , particularly following severe episodes. The American Association of Poison Control Centers (AAPCC) guidelines, as reflected in recent annual reports, underscore the role of benzodiazepines in managing acute to mitigate such risks. Prevention efforts focus on campaigns targeting over-the-counter (OTC) medication misuse, such as educating pharmacists and communities on the risks of high-dose antihistamines or antimuscarinics, alongside investigations to identify patterns in accidental deaths and inform policy.

Historical and Cultural Significance

Folklore and Occultism

Deliriants, particularly those derived from plants like and , have long been intertwined with shamanic practices among indigenous groups in , where they were employed to induce visions for and healing. Historical accounts from 16th-century Spanish chroniclers, such as , describe Aztec and other Mesoamerican peoples using species in rituals to communicate with deities and ancestors, often preparing infusions or smokes to facilitate interpreted as spiritual journeys. Similarly, in during the late 17th century, was associated with accusations, including tenuous links to the trials where hallucinatory symptoms were attributed to rather than , though direct evidence remains speculative. In traditions, deliriants featured prominently in "flying ointments" documented in 15th- and 16th-century grimoires and trial records, where atropine-rich plants like henbane and were smeared on the skin to enable and attendance at witches' sabbaths. These recipes, often involving animal fats as bases, appear in texts like the 1486 Malleus Maleficarum and later inquisitorial accounts, portraying the ointments as tools for transcending the physical realm into supernatural encounters. The revival of such practices in the 1970s neopagan movement, particularly within , saw modern witches experimenting with safer adaptations of these ointments for ritual trance states, drawing from historical sources to reclaim them as aids for personal . Hallucinations induced by deliriants were frequently interpreted in folklore as direct spirit communication or demonic possession, with users experiencing vivid encounters with otherworldly entities that reinforced beliefs in supernatural intervention. In Haitian Vodou myths, scopolamine from plants like contributed to tales of "" states, where victims appeared soulless and obedient, symbolizing the bokor's power to sever the soul from the body through a powder administered post-mortem simulation. Cross-culturally, held ritual significance in tantric practices, where it was offered to deities like in Ayurvedic-influenced ceremonies to invoke ecstatic visions, though its widespread use postdates early medieval introductions around the despite earlier textual allusions. In contemporary literature, works like Coby Michael's The Poison Path Herbal (2021) document reconstructed recipes using deliriant plants, emphasizing ethical sourcing and to avoid toxicity while preserving their mystical heritage.

Historical Uses and Incidents

The earliest documented uses of deliriants trace back to ancient civilizations, where plants like were employed for medicinal purposes. The , dating to approximately 1550 BCE, describes powdered hyoscyamus as a remedy to alleviate pain associated with intestinal worms, highlighting its role as a and in Egyptian pharmacology. In , was utilized as an during surgical procedures. , in his (circa 77 CE), notes that a potion of was administered to patients prior to incisions or punctures to induce insensibility to pain, underscoring its application in early operative contexts despite the risks of toxicity. During the medieval and periods, deliriants such as () were implicated in assassinations due to their potent toxic effects. A significant pharmacological advancement occurred in 1833 when atropine, the primary active in and other plants, was isolated by German chemists Philipp L. Geiger and Lorenz Hesse from the roots and leaves of , enabling more precise medical applications while revealing its deliriant properties. In the 19th and early 20th centuries, deliriants found experimental use in , notably through "," a combination of and introduced in the 1910s by German physicians Bernhard Kronig and Carl Gauss. This regimen aimed to reduce labor pain and induce but frequently resulted in , slowed respiration, and infant complications, leading to widespread criticism and eventual decline by the . The era saw informal experiments with species, particularly among anthropologists and seekers influenced by works like Carlos Castaneda's accounts of rituals, where Datura root teas were ingested for visionary experiences, often resulting in severe hallucinations and medical emergencies. Archaeological evidence further illuminates pre-Columbian Native American uses, with seeds and residues identified in sites across the American Southeast and western , including ceramic vessels and quids from as early as 1000 BCE, indicating ritualistic ingestion for altered states. Recent developments in the have prompted regulatory responses to deliriant risks among , particularly following teen deaths linked to the "Benadryl Challenge," where participants ingested excessive diphenhydramine to induce hallucinations; the U.S. issued public warnings in and monitored ongoing cases, contributing to calls for stricter over-the-counter packaging limits on antihistamines.

References

  1. [1]
    Understanding Central Nervous System Effects of Deliriant ...
    Jan 16, 2019 · Hallucinogenic drugs potently alter human behavior and have a millennia-long history of use for medicinal and religious purposes.Missing: definition | Show results with:definition
  2. [2]
    Acute behavioral effects of deliriant hallucinogens atropine and ...
    Feb 1, 2019 · Belonging to a group of deliriant hallucinogens, these drugs induce delirium-like hallucinations, hyperactivity, altered affective states and ...Missing: definition | Show results with:definition
  3. [3]
    DARK Classics in Chemical Neuroscience: Atropine, Scopolamine ...
    May 15, 2019 · Anticholinergic drugs based on tropane alkaloids, including atropine, scopolamine, and hyoscyamine, have been used for various medicinal and toxic purposes for ...
  4. [4]
    The Experience Elicited by Hallucinogens Presents the Highest ...
    Jan 22, 2018 · ... deliriant tropane alkaloids. Conversely, sedatives, stimulants ... hallucinogen drugs elicit experiences with the highest semantic similarity to ...
  5. [5]
    A Qualitative Analysis of First-Hand Accounts of Diphenhydramine ...
    Aug 31, 2023 · High doses of diphenhydramine (DPH), an over-the-counter antihistamine medication, can produce deliriant effects due to secondary ...
  6. [6]
    Perioperative Considerations for Patients Exposed to Hallucinogens
    Hallucinogen exposure in patients in the perioperative period presents ... anticholinergic deliriant hallucinogens. ACS chemical neuroscience, 2018. 10 ...
  7. [7]
    Atropine - LiverTox - NCBI Bookshelf - NIH
    Jul 7, 2017 · Atropine is a natural alkaloid anticholinergic agent that has potent antimuscarinic effects and is used by injection to treat symptomatic bradycardia, severe ...<|control11|><|separator|>
  8. [8]
    Scopolamine - StatPearls - NCBI Bookshelf - NIH
    Scopolamine is a medication used to manage and treat postoperative nausea and vomiting (PONV) and motion sickness. It is in the anticholinergic class of drugs.
  9. [9]
    Anticholinergic Toxicity - StatPearls - NCBI Bookshelf - NIH
    Anticholinergic toxicity is common in the emergency department but rarely fatal.[1] According to the 2015 annual American Association of Poison Control ...Anticholinergic Toxicity · Etiology · Treatment / ManagementMissing: recreational | Show results with:recreational
  10. [10]
    Anticholinergic Toxicity Clinical Presentation - Medscape Reference
    Jun 21, 2024 · Patients with central anticholinergic syndrome may present with the following: Ataxia. Disorientation. Short-term memory loss. Confusion.Missing: suggestibility reality
  11. [11]
    Delirium - Etymology, Origin & Meaning
    Originating in the 1590s from Latin delirium meaning "madness," derived from deliriare "be crazy," the word means a temporary disordered state or violent ...
  12. [12]
    History, Phenomenology, Nomenclature: Delirium: How Its Concept ...
    The term “delirium” was first used by Cclsus in the 1st century A.D., but on the whole the word “phrenitis” was used more often in the ancient medical ...
  13. [13]
    deliriant, adj. & n. meanings, etymology and more
    deliriant is of multiple origins. Either (i) formed within English, by derivation. Or (ii) a borrowing from Latin, combined with an English element.
  14. [14]
    Delirium: how its concept has developed - PubMed
    The development of the concept of delirium spans nearly 2,500 years. Its core clinical features were recognized at least as early as the 16th century, ...
  15. [15]
    DELIRIFACIENT definition in American English - Collins Dictionary
    Definition of 'delirifacient'. delirifacient in British English ... Word origin. C19: New Latin, literally: trembling delirium. Tile. Wordle Helper.
  16. [16]
    Hallucinogens - ScienceDirect.com
    The most popular names, hallucinogen, psychotomimetic, and psychedelic (“mind manifesting”; Osmond, 1957), have often been used interchangeably. Hallucinogen ...
  17. [17]
    The Psychopharmacology of Hallucinogens - Nature
    A chart review of 176 inpatients found that more psy- chotic patients abused hallucinogens than did a compa- rable group of drug abusers without psychosis. The.
  18. [18]
    Scopolamine: Uses, Interactions, Mechanism of Action - DrugBank
    Scopolamine is an anticholinergic belladonna alkaloid that, through competitive inhibition of muscarinic receptors, affects parasympathetic nervous system ...
  19. [19]
    Acute behavioral effects of deliriant hallucinogens atropine and ...
    Feb 1, 2019 · Belonging to a group of deliriant hallucinogens, these drugs induce delirium-like hallucinations, hyperactivity, altered affective states and ...
  20. [20]
    Properties of muscarinic receptors mediating second messenger ...
    The IC50 values were 55 +/- 4.3 nM, 81.2 +/- 6.5 microM and 13.3 +/- 3.5 microM, respectively. On the other hand, the inhibition of reduction in basal ...
  21. [21]
    mAChR Selective Inhibitors | Agonists | Antagonists | Modulators
    Scopolamine HBr is a competitive muscarinic acetylcholine receptor antagonist with an IC50 of 55.3 nM. Selective. S4713, Atropine, Atropine (Atropen, Atnaa, ...
  22. [22]
    Classics in Chemical Neuroscience: Deliriant Antihistaminic Drugs
    Nov 6, 2024 · Antihistaminic drugs also exert central nervous system (CNS) effects, acting as anxiolytics, hypnotics, and neuroleptics.Missing: definition | Show results with:definition
  23. [23]
    Understanding CNS effects of deliriant hallucinogenic drugs through ...
    Aug 20, 2025 · We comprehensively evaluate the preclinical effects of deliriant hallucinogens in various animal models, their mechanisms of action and potential interplay ...
  24. [24]
    Pharmacokinetics and pharmacodynamics in clinical use ... - PubMed
    In conclusion, scopolamine is used for premedication in anesthesia and for the prevention of nausea and vomiting associated with motion sickness.
  25. [25]
    Diphenhydramine - StatPearls - NCBI Bookshelf - NIH
    Mar 27, 2025 · Metabolism: Diphenhydramine undergoes substantial first-pass metabolism in the liver by the CYP450 system, predominantly by CYP2D6.[17].
  26. [26]
    Pharmacokinetics of Scopolamine in Serum and Subcutaneous ...
    The elimination half-life of scopolamine was 121 +/- 85 minutes in serum and 166 +/- 117 minutes in dialysate. Values for total clearance and volume of ...Missing: onset | Show results with:onset
  27. [27]
    Beauty of the beast: anticholinergic tropane alkaloids in therapeutics
    Sep 16, 2022 · Deliriant poisoning was prevalent among ... Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers.
  28. [28]
    Effects of first and second generation antihistamines on muscarinic ...
    Mar 24, 2005 · The first generation antihistamines, such as diphenhydramine, are fairly potent muscarinic antagonists in addition to being H1 selective antihistamines.Missing: reversible deliriants
  29. [29]
    Misuse of Anticholinergic Medications: A Systematic Review - MDPI
    Feb 1, 2022 · Neurological and psychiatric symptoms might include drowsiness, sedation, ataxia, amnesia, and finally coma; and paranoia, hallucinations, ...3. Results · 3.2. Benztropine · 4. Discussion
  30. [30]
    Anticholinergic Toxidrome • LITFL • Toxicology Flashcard Library
    Feb 28, 2024 · A play on the old mnemonic: mad as a hatter, hot as Hell, red as a beet, dry as a bone, and blind as a bat.
  31. [31]
    Clinical Practice Guidelines : Anticholinergic Syndrome
    Central inhibition leads to an agitated (hyperactive) delirium - typically including confusion, restlessness and picking at imaginary objects - which ...
  32. [32]
    Anticholinergic intoxication - EMCrit Project
    Aug 29, 2025 · High doses of benzodiazepine may perpetuate delirium, by generating a vicious cycle of ongoing delirium and benzodiazepine administration.
  33. [33]
    The cognitive impact of anticholinergics: A clinical review - PMC
    All but two studies found an association between the anticholinergic activity of medications and either delirium, cognitive impairment or dementia.
  34. [34]
    Anticholinergic Drugs in Geriatric Psychopharmacology - Frontiers
    This review presents different aspects of the use of anticholinergics in old age with a focus in psychogeriatric patients.
  35. [35]
    Physiology, Anticholinergic Reaction - StatPearls - NCBI Bookshelf
    The anticholinergic reaction is thought to be due to both central and peripheral antagonism of ACh at muscarinic receptors.Missing: psychological | Show results with:psychological
  36. [36]
    Nixing the nightshades: Traditional knowledge of intoxicating ...
    Feb 22, 2021 · Anticholinergic ... One stated that it is psychoactive, 2 that it is a deliriant, and one that it was either a deliriant or dissociative.
  37. [37]
    Tropane Alkaloids: Chemistry, Pharmacology, Biosynthesis and ...
    Feb 22, 2019 · They affect the central and peripheral nervous system as competitive, non-selective muscarinic acetylcholine receptor (mAChR) antagonists, that ...
  38. [38]
    Acute poisoning due to ingestion of Datura stramonium – a case report
    Datura stramonium toxicity usually occurs within 60 min after ingestion, and the clinical symptoms may persist up to 24 to 48 h, due to delayed gastric emptying ...
  39. [39]
    Anticholinergic Plants | California Poison Control System
    Dec 21, 2008 · Although atropine can be isolated in small quantities from the unripe skin of these “edible” plants, symptoms of toxicity are rare. Alkaloids ...
  40. [40]
    Antihistamines - StatPearls - NCBI Bookshelf - NIH
    First-generation antihistamines easily cross the blood-brain barrier into the central nervous system and antagonize H-1 receptors, leading to a different ...Missing: ethanolamine piperazine
  41. [41]
    Diphenhydramine: Uses, Interactions, Mechanism of Action
    Metabolism. Diphenhydramine undergoes rapid and extensive first-pass metabolism. In particular, two successive N-demethylations occur wherein ...
  42. [42]
    H1 Antihistamines: Current Status and Future Directions - PMC
    First-generation H1 antihistamines cross the blood-brain barrier, and in usual doses, they potentially cause sedation and impair cognitive function and ...
  43. [43]
    Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on ...
    This systematic review has illustrated a range of both themes and data regarding the misuse/abuse of some selected OTC drugs, including DXM, DPH, DH, codeine- ...
  44. [44]
    Diphenhydramine: It is time to say a final goodbye - ScienceDirect.com
    Feb 3, 2025 · In the 1970s, the pharmaceutical industry took advantage of these adverse effects and incorporated diphenhydramine into over-the-counter cough ...Missing: teenagers | Show results with:teenagers
  45. [45]
    FDA warns about serious problems with high doses of the allergy ...
    Oct 1, 2020 · Taking higher than recommended doses of the common over-the-counter (OTC) allergy medicine diphenhydramine (Benadryl) can lead to serious heart problems, ...
  46. [46]
    Muscimol as an ionotropic GABA receptor agonist - PubMed
    Muscimol is a psychoactive isoxazole from mushrooms and a selective agonist at ionotropic receptors for the inhibitory neurotransmitter GABA.
  47. [47]
    Amanita Muscaria vs. Psychedelic Mushrooms (Psilocybin)
    Apr 27, 2023 · Muscimol is a central nervous system depressant that may engage GABAa receptors to deliver sedative-hypnotic, depressant, and hallucinogenic ...
  48. [48]
    Health Care Utilization and Outcomes Associated with Accidental ...
    Mar 12, 2021 · An estimated 100 (SE = 22) hospitalizations associated with accidental mushroom ingestions occurred in 2016. The estimated mean length of stay ...Missing: cases | Show results with:cases
  49. [49]
    Acute Intoxications from Consumption of Amanita muscaria ... - CDC
    Minnesota, 2018 ... Weekly / May 31, 2019 / 68(21);483–484.
  50. [50]
    Ibogaine - an overview | ScienceDirect Topics
    Ibogaine is a dissociative psychedelic with oneiric properties that has multiple aforementioned antiaddictive mechanisms which target the stages of the ...
  51. [51]
    Anticholinergic delirium following Datura stramonium ingestion - NIH
    Recreational use of Datura to deliberately induce an anticholinergic delirium is not uncommon. We present a case of Datura intoxication in a young adult who ...
  52. [52]
    Monitoring the Future | National Institute on Drug Abuse (NIDA) - NIH
    Aug 29, 2024 · The MTF survey has measured drug and alcohol use and related attitudes among adolescent students nationwide.Missing: deliriant | Show results with:deliriant
  53. [53]
    Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low ...
    Dec 18, 2024 · Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey ; 4.4% of 8th graders; less than, but close, to the high ...
  54. [54]
    Substance Use in Popular Movies and Music
    Ninety-eight percent of movies depicted illicit drugs, alcohol, tobacco, or over-the-counter or prescription medicines. Substance use was almost never a central ...Missing: cultural | Show results with:cultural
  55. [55]
    [PDF] Reference ID: 3301616 This label may not be the latest approved by ...
    DOSAGE FORMS AND STRENGTHS​​ The Transderm Scōp system is a tan-colored circular flat patch which contains 1.5 mg of scopolamine base and is formulated to ...
  56. [56]
    Atropine sulfate (ophthalmic route) - Side effects & dosage
    Atropine sulfate eye drops is used to dilate the pupil before eye exams. It is also used to treat an eye condition called amblyopia (lazy eyes) and other eye ...
  57. [57]
    Atropine - StatPearls - NCBI Bookshelf - NIH
    Jul 6, 2025 · Special attention is given to atropine administration in emergency cardiac care, toxicologic interventions, and ophthalmic procedures.
  58. [58]
    Hyoscyamine: MedlinePlus Drug Information
    Sep 15, 2017 · Hyoscyamine is used to control symptoms associated with disorders of the gastrointestinal (GI) tract. It works by decreasing the motion of the stomach and ...
  59. [59]
    Hyoscyamine – Health Information Library | PeaceHealth
    Hyoscyamine is used in the treatment of peptic ulcers and of Parkinson's disease to reduce stiffness, tremors, and excess sweating.
  60. [60]
    The Use of Morphine and Scopolamine to Induce Twilight Sleep
    May 2, 2019 · Twilight sleep had many side effects. Scopolamine often disoriented pregnant women during labor, causing them to scream and thrash. ...
  61. [61]
    Muscarinic Receptors and Alzheimer's Disease: New Perspectives ...
    Jul 2, 2024 · A growing body of evidence advocating for the significance of muscarinic receptors in modulating the brain's capacity to adapt and generate new memories.
  62. [62]
  63. [63]
    A systematic literature review of clinical trials and therapeutic ...
    The published data suggest that ibogaine is an effective therapeutic intervention within the context of SUDs, reducing withdrawal symptoms and craving.
  64. [64]
    Jimsonweed (Datura stramonium) - Office of Justice Programs
    Jimsonweed is usually consumed in herbal tea mixtures; however, the seeds, leaves, and flower nectar can also be eaten or smoked. The high consists of delirium ...
  65. [65]
    (PDF) Psychedelics that Heal and Harm – Their Therapeutic and ...
    Sep 11, 2025 · Psychedelic drugs, known for their profound effects on perception, cognition, and emotion, have long captivated scientific, cultural, and ...
  66. [66]
    Atropine: Uses, Interactions, Mechanism of Action | DrugBank Online
    It has a variety of therapeutic applications, including pupil dilation and the treatment of anticholinergic poisoning and symptomatic bradycardia in the absence ...
  67. [67]
    Atropine - PubChem - NIH
    /HUMAN EXPOSURE STUDIES/ Atropine in toxic amounts leads to drowsiness, stupor, convulsions, & coma. A fatal dose may be as low as 1.6 mg & as high as 100 mg in ...
  68. [68]
    Datura stramonium seed ingestion leading to unintentional ...
    Oct 30, 2024 · In the case of the 3-year-old male toddler, his ingestion of Datura stramonium seeds led to symptoms consistent with anticholinergic toxicity, ...Missing: factors deliriant polysubstance
  69. [69]
    Physostigmine in Anticholinergic Poisoning: An Old Antidote With ...
    Nov 28, 2020 · The central role of physostigmine in anticholinergic delirium is to inhibit acetylcholinesterase. By inhibiting this enzyme, synaptic ...
  70. [70]
    [PDF] HALLUCINOGENS AND DISSOCIATIVE DRUGS - NIDA - NIH
    Hallucinogens such as LSD and psilocybin cause emotions to swing wildly and real-world sensations to appear unreal, sometimes frightening. Dissociative drugs ...
  71. [71]
    2023 Annual Report of the National Poison Data System® (NPDS ...
    Dec 17, 2024 · Results: In 2023, 2,421,251 closed encounters were logged by the National Poison Data System®: 2,080,659 human exposures, 41,857 animal ...Missing: anticholinergics | Show results with:anticholinergics
  72. [72]
    Over-the-Counter Drug Misuse and Dependence: Public Health ...
    Nov 20, 2022 · Misuse of and dependence on over-the-counter drugs are serious public health issues. Possible measures include stricter regulation and control.
  73. [73]
    Substance Use Prevention Campaigns, Events, and Observances
    Sep 19, 2025 · A national substance use prevention campaign that helps parents and caregivers, educators, and community members get informed, be prepared, and take action.
  74. [74]
    [PDF] The genus Datura L. (Solanaceae) in Mexico and Spain
    Mar 15, 2018 · In this work we make a historical review of the medicinal and ritualistic uses of the different species of Datura in Mexico and Spain, with ...
  75. [75]
    Babyfat and Belladonna: Witches' Ointment and the Contestation of ...
    Aug 6, 2025 · Witches' flying ointment—often cited in European witchcraft trials ... Salem witch trials stand out as the biggest witch hunt in history ...Missing: 1690s | Show results with:1690s
  76. [76]
    Witches, potions, and metabolites: an overview from a medicinal ...
    This review carries out an analysis on two of the most famous witch potions, the so-called sleep and love potion, intersecting between chemistry and culture ...
  77. [77]
    The poison path herbal : baneful herbs, medicinal nightshades, and ...
    The Witch's Flying Ointment. The Crossroads on the Path of Poison. The Book of Saturn: Baneful Herbs and Dark Workings. The Book of Mercury: Traversing the ...
  78. [78]
    Revisiting the Ethnobiology of the Zombie Poison - PubMed Central
    His research was an attempt to trace the origins of reports of “undead” Haitians, focusing on the preparation of the zombification poison. Starting with this ...
  79. [79]
    [PDF] Historical evidence for a pre-Columbian presence of Datura in the ...
    Dec 4, 2007 · Recent studies suggest Datura originated in the Americas, but historical evidence and misinterpretations of texts suggest a pre-Columbian Old ...
  80. [80]
    Papyrus of Ebers and Smith
    Among the medicines mentioned in the papyrus of Ebers, ox liver against night blindness, powdered hyoscyamus to expel pain caused by worms, and a favourite ...
  81. [81]
    Pliny the Elder on Mandragora - Utopian Surgery?
    [mandragora is] given for injuries inflicted by serpents and before incisions or punctures are made in the body, in order to insure insensibility to pain.Missing: mandrake | Show results with:mandrake
  82. [82]
  83. [83]
    Journal of Traditional Medicine & Clinical Naturopathy - Atropine
    Feb 6, 2018 · Atropine itself was discovered in 1809 by Vacquelin and isolated in 1831 by Mein [2]. ... Geiger PL, Hesse H (1833) Darstellung des Atropine: ...Missing: Hess | Show results with:Hess
  84. [84]
    Twilight Sleep: the Horrifying Way Early 20th Century Women Gave ...
    Aug 29, 2024 · As scopolamine had a tendency to induce violent delirium, the original “Freiburg Method” for twilight sleep placed great emphasis on sensory ...Missing: deliriant | Show results with:deliriant
  85. [85]
    Carlos Castaneda | Research Starters - EBSCO
    In the spring of 1960, as part of his research for a term paper on the datura plant for Meighan's class, Castaneda began traveling into the Arizona desert to ...<|separator|>
  86. [86]
    [PDF] Psychopharmacology in Jails: An Introduction - Antonio Casella
    High doses of diphenhydramine, up to 150 mg or even 200 mg qhs, are surprisingly well-tolerated by many inmates— perhaps because many have abused sedating ...
  87. [87]
    Stereosonic music festival: 20 overdose in Brisbane despite extra ...
    Dec 7, 2015 · Queensland authorities say the number of people treated for drug overdoses at the Stereosonic music festival in Brisbane was staggering.
  88. [88]
    Absorbed Residue Evidence for Prehistoric Datura Use in the ...
    Oct 4, 2018 · In this article we use mass spectrometry to identify Datura residues in prehistoric contexts from western Mexico and the American Southeast.
  89. [89]
    The 'Benadryl Challenge' Is Gaining Steam on TikTok. Addiction ...
    Sep 19, 2025 · The trend involves teens downing a handful of allergy pills and filming themselves as the hallucinations take over. The FDA has already tied the ...